Production (Stage)
Kodiak Sciences Inc.
KOD
$4.22
$0.307.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 7.09% | -2.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 27.92% | -0.97% | |||
| Operating Income | -27.92% | 0.97% | |||
| Income Before Tax | -30.28% | -0.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -30.28% | -0.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.28% | -0.36% | |||
| EBIT | -27.92% | 0.97% | |||
| EBITDA | -31.09% | 0.94% | |||
| EPS Basic | -30.05% | -0.30% | |||
| Normalized Basic EPS | -30.04% | -0.31% | |||
| EPS Diluted | -30.05% | -0.30% | |||
| Normalized Diluted EPS | -30.04% | -0.31% | |||
| Average Basic Shares Outstanding | 0.18% | 0.07% | |||
| Average Diluted Shares Outstanding | 0.18% | 0.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||